HIP REPLACEMENT SURGERY (ARTHROPLASTY)
|
|
- Noel Goodman
- 6 years ago
- Views:
Transcription
1 Prtcl: ORT015 Effective Date: June 1, 2017 HIP REPLACEMENT SURGERY (ARTHROPLASTY) Table f Cntents Page COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE... 3 U.S.FOOD AND DRUG ADMINISTRATION (FDA)... 4 APPLICABLE CODES... 5 PROTOCOL HISTORY/REVISION INFORMATION... 5 INSTRUCTIONS FOR USE This prtcl prvides assistance in interpreting UnitedHealthcare benefit plans. When deciding cverage, the enrllee specific dcument must be referenced. The terms f an enrllee's dcument (e.g., Certificate f Cverage (COC) r Evidence f Cverage (EOC)) may differ greatly. In the event f a cnflict, the enrllee's specific benefit dcument supersedes this prtcl. All reviewers must first identify enrllee eligibility, any federal r state regulatry requirements and the plan benefit cverage prir t use f this Prtcl. Other Prtcls, Plicies and Cverage Determinatin Guidelines may apply. UnitedHealthcare reserves the right, in its sle discretin, t mdify its Prtcls, Plicies and Guidelines as necessary. This prtcl is prvided fr infrmatinal purpses. It des nt cnstitute medical advice. This plicy des nt gvern Medicare Grup Retiree members. UnitedHealthcare may als use tls develped by third parties, such as the MCG Care Guidelines, t assist us in administering health benefits. The MCG Care Guidelines are intended t be used in cnnectin with the independent prfessinal medical judgment f a qualified health care prvider and d nt cnstitute the practice f medicine r medical advice. COMMERCIAL & MEDICAID COVERAGE RATIONALE Fr infrmatin regarding medical necessity review, when applicable, see MCG Care Guidelines, 21st Editin, 2017Hip Arthrplasty, S-560 (ISC), accessed April MCG Care Guidelines: Hip Arthrplasty, S-560 Clinical Indicatins fr Prcedure: Prcedure is indicated fr 1 r mre f the fllwing: Degenerative jint disease as indicated by ALL f the fllwing: Presence f significant radigraphic findings (eg, hip jint destructin, severe narrwing, bne defrmities, stenecrsis) Optimal medical management has been tried and failed (eg, analgesics, NSAIDs, physical therapy) Patient has failed r is nt a candidate fr mre cnservative measures (eg, stetmy, hemiarthrplasty) Hip Replacement Surgery (Arthrplasty) Page 1 f 6
2 Treatment is needed because f 1 r mre f the fllwing: Disabling pain Functinal disability Primary and secndary tumrs invlving the prximal femur Ostenecrsis f femral head Develpmental dysplasia f hip Displaced fracture f the femral neck in a patient withut significant cgnitive impairment Acetabular fracture Pertrchanteric fracture and 1 r mre f the fllwing: Ipsilateral hip stearthritis Ipsilateral avascular necrsis f the femral head Inflammatry arthritis Cmminuted, significantly displaced, r unstable fracture Pr bne quality (eg, thin crtices, wide intramedullary canal n imaging) Cmplicatin f internal fixatin Neglected fracture Failed previus hip fracture fixatin Revisin f hip arthrdesis Revisin f previus arthrplasty r resurfacing indicated by 1 r mre f the fllwing: Instability f ne r bth cmpnents Fracture r mechanical failure f the implant Recurrent r irreducible dislcatin Infectin Treatment f a periprsthetic fracture Tissue r systemic reactin t metal implant Leg-length inequality **End f MCG Fr infrmatin regarding medical necessity review, when applicable, see MCG Care Guidelines, 21st Editin, 2017, Hip: Displaced Fracture f Femral Neck, Hemiarthrplasty, S-600 (ISC), accessed April MCG Care Guidelines: Hip: Displaced Fracture f Femral Neck, Hemiarthrplasty, S-600 (ISC) Clinical Indicatins fr Prcedure Prcedure is indicated fr 1 r mre f the fllwing: Displaced fracture f femral neck in lder patient (eg, 65 years r lder) Fracture-dislcatin f hip in lder patient (eg, 65 years r lder) Reductin r fixatin f hip fracture that cannt be maintained Recent histry f failed fixatin f femral neck fracture Fracture f neck f femur with cmplete dislcatin f femral head Fracture superimpsed upn pre-existing lesins f hip (eg, radiatin changes, severe arthritis) Fracture f femral neck in patient with psychsis r severe cgnitive impairment Pathlgic fracture f femral neck Pertrchanteric fracture and 1 r mre f the fllwing: Hip Replacement Surgery (Arthrplasty) Page 2 f 6
3 Ipsilateral hip stearthritis Ipsilateral avascular necrsis f the femral head Inflammatry arthritis Cmminuted, significantly displaced, r unstable fracture Pr bne quality (eg, thin crtices, wide intramedullary canal n imaging) Cmplicatin f internal fixatin Neglected fracture ***End f MCG MEDICARE COVERAGE RATIONALE Medicare des nt have a Natinal Cverage Determinatin, but des have a Lcal Cverage Determinatin fr Nevada fr Ttal Jint Arthrplasty (L34163) (Accessed April 2017). Ttal Jint Arthrplasty (L34163) Ttal Hip Arthrplasty (THA) Ttal hip replacement surgery is medically necessary when ne r mre f the fllwing criteria* are met: Advanced jint disease demnstrated by: Radigraphic supprted evidence r when cnventinal radigraphy is nt adequate, magnetic resnance imaging (MRI) supprted evidence (subchndral cysts, subchndral sclersis, periarticular stephytes, jint subluxatin, jint space narrwing, avascular necrsis); and Pain that cannt be adequately cntrlled despite ptimal cnservative treatment r functinal disability frm injury due t trauma r arthritis f the jint); and If apprpriate, histry f unsuccessful cnservative therapy (nn-surgical medical management) that is clearly addressed in the pre prcedure medical recrd. (If cnservative therapy is nt apprpriate, the medical recrd must clearly dcument the ratinale fr why such apprach is nt reasnable); r Malignancy f the jint invlving the bnes r sft tissues f the pelvis r prximal femur; r Avascular necrsis (stenecrsis f femral head); r Fracture f the femral neck; r Acetabular fracture; r Nn-unin r failure f previus hip fracture surgery; r Mal-unin f acetabular r prximal femur fracture *See Assciated Infrmatin Dcumentatin Requirements fr additinal infrmatin. Nn-surgical medical management is usually but nt always implemented prir t scheduling ttal jint surgery. Nn-surgical treatment as clinically apprpriate fr the patient s current episde f care typically includes ne r mre f the fllwing: anti-inflammatry medicatins r analgesics, r flexibility and muscle strengthening exercises, r supervised physical therapy [Activities f daily living (ADLs) diminished despite cmpleting a plan f care], r assistive device use, r Hip Replacement Surgery (Arthrplasty) Page 3 f 6
4 weight reductin as apprpriate, r therapeutic injectins int the hip as apprpriate. Indicatins fr Replacement/Revisin f Ttal Hip Arthrplasty Lsening f ne r bth cmpnents; r Fracture r mechanical failure f the implant; r Recurrent r irreducible dislcatin; r Infectin; r Treatment f a displaced periprsthetic fracture; r Clinically significant leg length inequality nt amenable t cnservative management; r Prgressive r substantial bne lss; r Bearing surface wear leading t symptmatic synvitis r lcal bne r sft tissue reactin; r Clinically significant audible nise; r Adverse lcal tissue reactin Limitatins Ttal knee replacement r ttal hip replacement is nt medically necessary when the fllwing cntraindicatins are present: Active infectin f the hip r knee jint r active systemic bacteremia Active skin infectin (exceptin recurrent cutaneus staph infectins) r pen wund within the planned surgical site f the hip r knee Rapidly prgressive neurlgical disease except in the clinical situatin f a cncmitant displaced femral neck fracture The fllwing cnditins are relative cntraindicatins t ttal knee r ttal hip replacement and if such surgery is perfrmed in the presence f these cnditins, it is expected that the ratinale fr prceeding with the surgery under such circumstances is clearly dcumented in the medical recrd: Absence r relative insufficiency f abductr musculature Any prcess that is rapidly destrying bne Neurtrphic arthritis Fr Medicare and Medicaid Determinatins Related t States Outside f Nevada: Please review Lcal Cverage Determinatins that apply t ther states utside f Nevada. Imprtant Nte: Please als review lcal carrier Web sites in additin t the Medicare Cverage database n the Centers fr Medicare and Medicaid Services Website. U.S.FOOD AND DRUG ADMINISTRATION (FDA) Hip replacement surgery is a prcedure and therefre is nt regulated by the FDA. Hwever, devices and instruments used during the surgery require FDA apprval. Several devices have FDA apprval. Additinal infrmatin (prduct cde MEH, JDI, JDG, LWJ, LPH, LZO, KWY, KWA) is available at: Accessed April Hip Replacement Surgery (Arthrplasty) Page 4 f 6
5 The FDA-apprved ttal hip arthrplasty (THA) devices are generally apprved fr the same indicatins, including any r all f the fllwing: Severe hip pain and disability due t stearthritis (OA), rheumatid arthritis (RA), traumatic arthritis (TA), plyarthritis, cllagen disrders, avascular necrsis f the femral head, r nnunin f prir femral fracture. Cngenital hip dysplasia, prtrusia acetabuli (bulging f the femral head int the pelvis), r slipped capital femral epiphysis. Disability due t previus fusin. Acute femral neck fracture. APPLICABLE CODES The fllwing list(s) f prcedure and/r diagnsis cdes is prvided fr reference purpses nly and may nt be all inclusive. Listing f a cde in this plicy des nt imply that the service described by the cde is a cvered r nn- cvered health service. Benefit cverage fr health services is determined by the member specific benefit plan dcument and applicable laws that may require cverage fr a specific service. The inclusin f a cde des nt imply any right t reimbursement r guarantee claim payment. Other Plicies and Cverage Determinatin Guidelines may apply. CPT Cdes Descriptin Acetabulplasty; (e.g., Whitman, Clnna, Haygrves, r cup type) Acetabulplasty; resectin, femral head (e.g., Girdlestne prcedure) Hemiarthrplasty, hip, partial (e.g., femral stem prsthesis, biplar arthrplasty) Arthrplasty, acetabular and prximal femral prsthetic replacement (ttal hip arthrplasty), with r withut autgraft r allgraft Cnversin f previus hip surgery t ttal hip arthrplasty, with r withut autgraft r allgraft Revisin f ttal hip arthrplasty; bth cmpnents, with r withut autgraft r allgraft Revisin f ttal hip arthrplasty; acetabular cmpnent nly, with r withut autgraft r allgraft Hip Revisin f ttal hip arthrplasty; femral cmpnent nly, with r withut allgraft CPT is a registered trademark f the American Medical Assciatin PROTOCOL HISTORY/REVISION INFORMATION Date 04/27/ /28/ /25/ /25/ /22/ /19/ /28/2013 Actin/Descriptin Crprate Medical Affairs Cmmittee Hip Replacement Surgery (Arthrplasty) Page 5 f 6
6 04/26/ /23/2012 The freging Health Plan f Nevada/Sierra Health & Life Health Operatins prtcl has been adpted frm an existing UnitedHealthcare cverage determinatin guideline that was researched, develped and apprved by the UnitedHealthcare Cverage Determinatin Cmmittee. Hip Replacement Surgery (Arthrplasty) Page 6 f 6
Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationOTHER AND UNSPECIFIED DISORDERS
OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More informationFolotyn (pralatrexate)
Fltyn (pralatrexate) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 01/01/2018TBD03/01/2017 POLICY A. INDICATIONS The indicatins
More informationLEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST
OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers
Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More informationOriginal Policy Date
MP 7.01.113 Orthgnathic Surgery Medical Plicy Sectin Surgery Issue 12/2013 Original Plicy Date 12/2013 Last Review Status/Date Lcal Plicy created 12/2013 Return t Medical Plicy Index Disclaimer Our medical
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)
Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember
More informationFee Schedule - Home Health Care- 2015
Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers
Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer
More informationOriginal Date: December 2015 Page 1 of 8 FOR CMS (MEDICARE) MEMBERS ONLY
National Imaging Associates, Inc. Clinical guidelines TOTAL JOINT ARTHROPLASTY -Total Hip Arthroplasty -Total Knee Arthroplasty -Replacement/Revision Hip or Knee Arthroplasty CPT4 Codes: Please refer to
More informationNIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO
NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram
More informationDrug Therapy Guidelines
Applicable* Medical Benefit x Effective: 2/15/19 Pharmacy- Frmulary 1 Next Review: 12/19 Pharmacy- Frmulary 2 Date f Origin: 4/1/05 Pharmacy- Frmulary 3/Exclusive Review Dates: 4/1/05, 2/1/06, 10/15/06,
More informationIndications and Limitations of Coverage and/or Medical back to top
Fr services perfrmed n r after 09/15/2009 Original Determinatin Ending Date Revisin Effective Date Revisin Ending Date Indicatins and Limitatins f Cverage and/r Medical Necessity Indicatins Medicare cverage
More informationo Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient
Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University
More informationContinuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP
Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit
More informationItay Perets, MD Lyall Ashberg, MD Edwin O. Chaharbakhshi, BS, John P. Walsh, MA Mary R. Close, BS Benjamin G. Domb, MD. Hinsdale Orthopaedics
Clinical utcmes and return t sprt in cmpetitive athletes underging ilipsas fractinal lengthening as a part f hip arthrscpy minimum 2 year fllw-up Itay Perets, MD Lyall Ashberg, MD Edwin O. Chaharbakhshi,
More informationRituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage
Rituxan (rituximab) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Effective Date: 10/01/2015 POLICY A. INDICATIONS The indicatins belw including FDA-apprved indicatins and cmpendial uses
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Orencia (abatacept) Applicable Medical Benefit x Effective: 2/21/18 Pharmacy- Frmulary 1 x Next Review: 12/18 Pharmacy- Frmulary 2 x Date f Origin: 11/28/06 Pharmacy- Frmulary 3/Exclusive
More informationAnterior Total Hip Arthroplasty Patient Guide & Common Questions
Intrductin: Anterir Ttal Hip Arthrplasty Patient Guide & Cmmn Questins This handut is a general guide t cmmn indicatins fr anterir ttal hip arthrplasty, what t expect when underging the prcedure, risks,
More informationBenefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016
Benefits t Change fr Diagnstic and Surgical/Recnstructive Breast Therapies and Crrective Prcedures January 1, 2016 Infrmatin psted Nvember 13, 2015 Effective fr dates f service n r after January 1, 2016,
More informationInstructions for Use Reprocessed Non Sterile External Fixation Devices
Reprcessed by Instructins fr Use Reprcessed Nn Sterile External Fixatin Devices Reprcessed Device fr Single Use Cautin: Federal (U.S.A.) law restricts this device t sale by r n the rder f a physician.
More informationErythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals
(Subcutaneus/Intravenus) Last Review Date: January 1, 2019 Number: MG.MM.PH.80 *NON-DIALYSIS* Medical Guideline Disclaimer C All rights reserved. The treating physician r primary care prvider must submit
More informationInternational Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1
Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More information2016 CWA Political Action Fund Administrative Procedures Checklist
2016 CWA Plitical Actin Fund Administrative Prcedures Checklist 1. Dates f Prgram The 2016 CWA Plitical Actin Fund (federal plitical actin cmmittee- CWA-COPE PCC) Prgram will be cnducted n a calendar year
More informationMRI LOWER EXTREMITIES IMAGING FACT SHEET. MRI Lower Extremities
MRI Lwer Extremities When calling Anthem (1-800-533-1120) r using the Pint f Care authrizatin system fr a Health Service Review, the fllwing clinical infrmatin may be needed t prcess yur request. Being
More informationMEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache
MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management
More informationPODIATRY Delineation of Clinical Privileges
PODIATRY Delineatin f Clinical Privileges Criteria fr granting privileges: Pdiatry Cre I - Current bard certificatin by the American Bard f Pdiatric Medicine (ABPM). Or Successful cmpletin f a Cuncil n
More informationPolicy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning
Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening
More informationOntario s Referral and Listing Criteria for Adult Lung Transplantation
Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral
More information2017 CMS Web Interface
CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationFor Commercial products, please refer to the following policy: Preauthorization via Web-Based Tool for Procedures
Medical Coverage Policy Total Joint Arthroplasty Hip and Knee EFFECTIVE DATE: 08/01/2017 POLICY LAST UPDATED: 06/06/2017 OVERVIEW Joint replacement surgery, also known as arthroplasty, has proved to be
More informationUpdates to Medical Policies and Clinical UM Guidelines Effective January 15, 2012
Updates t Medical Plicies and Clinical UM Guidelines Effective January 15, 2012 UniCare is pleased t prvide yu with ur updated and new medical plicies and clinical UM guidelines. The majr new new plicies
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationSPINRAZA (NUSINERSEN)
SPINRAZA (NUSINERSEN) UnitedHealthcare Oxfrd Clinical Plicy Plicy Number: PHARMACY 295.4 T2 Effective Date: April 1, 2018 Table f Cntents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE... 1 BENEFIT
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationMIDLAND MEMORIAL HOSPITAL Delineation of Privileges ORTHOPEDIC SURGERY
MIDLAND MEMORIAL HOSPITAL Delineatin f Privileges ORTHOPEDIC SURGERY Physician Name: Yur hme fr healthcare Orthpedic Surgery Cre Privileges Qualificatins Minimum threshld criteria fr requesting privileges
More informationDiabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)
Rule Categry: Medical ` Ref: N: 2013-MN-0012 Versin Cntrl: Versin N. 1.1 Effective Date: December 2013 Revisin Date: December 2014 Diabetes Mellitus Lab Tests (Screening, Diagnsis & Mnitring) Adjudicatin
More informationPROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.
Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationUNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.
Initial privileges (initial appintment) Renewal f privileges (reappintment) Expansin f privileges (mdificatin) INSTRUCTIONS All new applicants must meet the fllwing requirements as apprved by the UNM SRMC
More informationo Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17
Request fr Prir Authrizatin Pulmnary Arterial Hypertensin (PAH) Agents (Oral and Inhaled) Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 All requests fr Pulmnary Arterial
More informationPhysical Fitness for the Physically Limited. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses
SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: 5. Subject: 6. Shrt Curse Title: 7. Effective Term:: KINL 2 Physical Fitness fr the Physically Limited Kinesilgy & Athletics
More informationA foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:
RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationStructured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information
Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in
More informationcerliponase alfa (Brineura )
cerlipnase alfa (Brineura ) Applies t all prducts administered r underwritten by Blue Crss and Blue Shield f Luisiana and its subsidiary, HMO Luisiana, Inc.(cllectively referred t as the Cmpany ), unless
More informationMethadone Maintenance Treatment for Opioid Dependence
POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin
More informationGuideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations
Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More informationImmunisation and Disease Prevention Policy
Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries
More informationClinical Policy: Vedolizumab (Entyvio) Reference Number: ERX.SPA.163 Effective Date:
Clinical Plicy: Vedlizumab (Entyvi) Reference Number: ERX.SPA.163 Effective Date: 10.01.16 Last Review Date: 11.18 Revisin Lg See Imprtant Reminder at the end f this plicy fr imprtant regulatry and legal
More informationA Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013
A Unified Apprach t Cnflict Mineral Cmpliance fr the Tungsten Industry The Westin, Sydney, 23 September 2013 Backgrund Cmpliance f public US dwnstream tungsten users with the reprting requirements f the
More informationContinuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator
Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results
More informationGUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH
GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationSCALES NW HEARING PROTECTION PROGRAM
PURPOSE Expsure t excessive nise in the wrkplace can cause permanent hearing lss. The Hearing Prtectin Prgram has been established t help ensure that emplyees f Scales NW, Inc. d nt suffer health effects
More information2017 CMS Web Interface
CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...
More information2017 CMS Web Interface
CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF 0055): Diabetes: Eye Exam Measure Steward: NCQA Web Interface
More informationGuideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations
Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT DENERVATION (RADIOFREQUENCY NEUROLYSIS) CPT Cdes: Cervical Thracic Regin: 64633, +64634 Lumbar Sacral Regin: 64635, +64636
More informationBreast Surgery Corporate Medical Policy
File name: Breast Surgery File cde: UM.SURG.17 Originatin: 2016 Last Review: 07/2018 (PA list review) Next Review: 08/2019 Effective Date: 08/01/2018 Breast Surgery Crprate Medical Plicy Descriptin/Summary
More information2018 CMS Web Interface
CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF Measure Steward: NCQA CMS Web Interface V2.1 Page 1 f 26
More informationMylotarg (gemtuzumab ozogamicin) (Intravenous)
Myltarg (gemtuzumab zgamicin) (Intravenus) Last Review Date: 09/19/2017 Date f Origin: 09/19/2017 Dates Reviewed: 09/2017 Dcument Number: IC-0320 I. Length f Authrizatin Newly-Diagnsed AML De nv disease
More informationPage 1 of 5. Fast Facts. CTC v.4; AJCC 7 th ed. Herceptin provided
Page 1 f 5 NSABP B-47 - A Randmized Phase III Trial f Adjuvant Therapy Cmparing Chemtherapy Alne (Six Cycles f Dcetaxel Plus Cyclphsphamide r Fur Cycles f Dxrubicin Plus Cyclphsphamide Fllwed by Weekly
More informationContinuous or Intermittent Monitoring of Glucose in Interstitial Fluid
Medical Plicy 1.01.20 Cntinuus r Intermittent Mnitring f Glucse in Interstitial Fluid Sectin 1.0 Durable Medical Equipment Subsectin Effective Date February 27, 2015 Original Plicy Date February 23, 2000
More informationEAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL
EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL Cncussin awareness has increased significantly in recent years. The Natinal Cllegiate Athletic Assciatin (NCAA), Natinal Athletic Trainers Assciatin
More informationNutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:
Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin
More informationSubject: Panniculectomy/Removal of Redundant Skin and Subcutaneous Tissue
Medical Review Criteria Panniculectmy/ Remval f Redundant Tissue Subject: Panniculectmy/Remval f Redundant Skin and Subcutaneus Tissue Backgrund: Panniculectmy is the remval f a large fld f redundant abdminal
More information2018 CMS Web Interface
CMS Web Interface HTN-2 (NQF 0018): Cntrlling High Bld Pressure Measure Steward: NCQA CMS Web Interface V2.0 Page 1 f 18 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4
More informationMeeting the Nutritional Requirements of Individuals with Dementia
Unit 15: Understanding and Meeting the Nutritinal Requirements f Individuals with Dementia Unit reference number: D/616/7124 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 26 Unit summary
More informationADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Extremities. EFFECTIVE JANUARY 1, 2019 Proprietary
CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: EFFECTIVE JANUARY 1, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm
More informationSANTIS Pedicle Screw System Please read carefully INSTRUCTIONS FOR USE
SANTIS Pedicle Screw System Please read carefully INSTRUCTIONS FOR USE Package Insert Santis Pedicle Screw System IMPORTANT NOTE The users acknwledge that they have read and agreed n the cnditins in this
More informationDocumentation Requirements for LL Prosthetics
Ottbck has relied upn the CMS guidance and recmmendatins set frth in this dcument s reference sectin belw. Medicare s Criteria in a Nutshell Medical necessity fr prsthetic cmpnents r additins t the prsthesis
More informationDISTRIBUTION: ORGANIZATION WIDE APPROVED BY: VP COMPLIANCE
LAST REVISED: Page 1 f 5 POLICY CarePint Health (Baynne Medical Center, Christ Hspital, Hbken University Medical Center, CarePint Health Medical Grup, Garden State Healthcare Assciates, CarePint Health
More informationDental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.
Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,
More informationThis standard operating procedure applies to stop smoking services provided by North 51.
Authr Name/Title Melanie McIlvar, Bid Develpment Manager Authr Signature Date: 4 th September 2017 Apprver Name/Title Jasn Shelley, Grup Directr f QA/RA Apprver Signature Date: 4 th September 2017 Issue
More informationPage New: Ophthalmologic Policy - Vascular Endothelial Growth Factor (VEGF) - Effective May 1,
March 2014 Page New: Ophthalmlgic Plicy - Vascular Endthelial Grwth Factr (VEGF) - Effective May 1, 2014. 2 Updated: Fecal DNA Testing - Effective Apr. 1, 2014... 3 Platelet Derived Grwth Factrs fr Treatment
More informationITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.
Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet
More informationSpecifically, on page 12 of the current evicore draft, we find the statement:
Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit
More informationPerjeta (pertuzumab) Document Number: IC I. Length of Authorization. Dosing Limits. Initial Approval Criteria
Perjeta (pertuzumab) Last Review Date: 11/21/2017 Date f Origin: 11/01/2012 Dcument Number: IC-0096 Dates Reviewed: 12/2012, 3/2013, 6/2013, 9/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014, 3/2015,
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationTEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS
TABLE OF CONTENTS CPT t LCD ID... 4 L26500- Autmatic Implantable Cardiac Defibrillatr (AICD) - 4C-58AB... 14 L26529- Cardiac Catheterizatin - 4C-50AB... 23 L26534- Transthracic Echcardigraphy (TTE) - 4C-52AB...
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable* Hereditary Angiedema (HAE) Agents: Berinert (C1 esterase inhibitr [human]), Cinryze (C1 esterase inhibitr [human]), Haegarda (C1 esterase inhibitr [human]) Kalbitr (ecallantide),
More informationDrug Therapy Guidelines
Applicable Medical Benefit x Effective: 5/1/18 Pharmacy- Frmulary 1 x Next Review: 3/18 Pharmacy- Frmulary 2 x Date f Origin: 4/99 Gnadtrpin-Releasing Hrmne Agnists- Eligard, Luprn, Luprn-Dept, Luprn Dept-Ped,
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationP02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017
P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...
More informationAll indications: 60 billable units every 6 months. Giant Cell Tumor of Bone; Hypercalcemia of malignancy
Last Review Date: January 1, 2019 Number: MG.MM.PH.100 Medical Guideline Disclaimer C All rights reserved. The treating physician r primary care prvider must submit t EmblemHealth the clinical evidence
More informationKent and Medway Policy Recommendation and Guidance Committee Policy Recommendation
Kent and Medway Plicy Recmmendatin and Guidance Cmmittee Plicy Recmmendatin Plicy: PR 2017-11: Surgery fr haemrrhids Issue date: July 2017 Review date: July 2020 The Kent and Medway Plicy Recmmendatin
More informationSunny Smiles Pediatric Dentistry
Sunny Smiles Pediatric Dentistry Patient: Tday s Date: Nickname/Preferred Name: Date f Birth: Age: Sex: M F Schl: Grade: Hme Address: City: Zip: Phne Number: Scial Security Number: Wh has legal custdy
More information